Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Trial of Late Surfactant for Prevention of Bronchopulmonary Dysplasia: A Study in Ventilated Preterm Infants Receiving Inhaled Nitric Oxide

Trial Profile

Trial of Late Surfactant for Prevention of Bronchopulmonary Dysplasia: A Study in Ventilated Preterm Infants Receiving Inhaled Nitric Oxide

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 21 Jul 2022

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Calfactant (Primary)
  • Indications Bronchopulmonary dysplasia
  • Focus Therapeutic Use
  • Acronyms TOLSURF

Most Recent Events

  • 04 Apr 2018 Results (n=420) of secondary analysis evaluating the relationship between maternal self-reported race/ethnicity and persistent wheezing illness in former high-risk, extremely low gestational age newborns, and quantifying the contribution of socioeconomic, environmental, and biological factors published in the Journal of Pediatrics
  • 16 Jan 2017 Results assessing effects on respiratory outcomes at 1 year corrected age (n=450) published in the Journal of Pediatrics
  • 20 Oct 2015 Results published in the Journal of Pediatrics

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top